Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a named patient programme at a single UK center
Gibb, Adam Jones, Craig Bloor, Adrian Kulkarni, Samar
Gibb, Adam
Jones, Craig
Bloor, Adrian
Kulkarni, Samar
Citations
Altmetric:
Abstract
Description
Date
2013
Publisher
Collections
Keywords
Type
Article
Citation
Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a named patient programme at a single UK center 2012, 98 (4):611 Haematologica